Norway allocates additional US$218 million to Access to COVID-19 Tools Accelerator

The Norwegian government is allocating an additional NOK2.0 billion (US$218 million) to Access to COVID-19 Tools Accelerator (ACT-A), the "global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines". The total funding now consists of NOK4.5 billion (US$492 million), which will be distributed over the period of 2021-2030.

NOK780 million (US$85 million) will go to three pillars: treatment, diagnostics, and strengthening of local health systems. NOK95 million (US$10 million) will be allocated to the Global Fund to fight Aids, Tuberculosis, and Malaria.

Press release - The Norwegian government